NYSEMKT: USBCUsbc Inc Stock
$1.34-0.01 (-0.74%)
Updated Sep 30, 2025
USBC Price
$1.34
Fair Value Price
N/A
Market Cap
$10.05M
52 Week Low
$0.33
52 Week High
$14.80
P/E
-0.27x
P/B
-2.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$13.41M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.1
Operating Cash Flow
-$8M
Beta
-39.85
Next Earnings
Nov 14, 2025
Ex-Dividend
N/A
Next Dividend
N/A
USBC Overview
Know Labs, Inc., develops, markets, and sells proprietary technologies in the United States. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilize electromagnetic energy along the electromagnetic spectrum to perform analytics, which allow the user to identify, authenticate, and diagnose various organic and non-organic materials and substances. The company, through its subsidiary TransTech Systems, Inc., distributes products for employee and personnel identification and authentication. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine USBC's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Scientific & Technical Instrument
Industry Rating
B
USBC
Ranked#24 of 25
Ranked#24 of 25
Be the first to know about important USBC news, forecast changes, insider trades & much more!
USBC News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how USBC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
USBC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
USBC is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
USBC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more USBC due diligence checks available for Premium users.
Valuation
USBC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.27x
Industry
17.27x
Market
37.24x
USBC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-2.1x
Industry
3.4x
USBC's financial health
Profit margin
Revenue
$0.0
Net Income
-$1.5M
Profit Margin
0%
USBC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$492.6k
Liabilities
$5.3M
Debt to equity
-1.1
USBC's short-term liabilities ($5.13M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
USBC's short-term assets ($172.50k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
USBC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
USBC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.3M
Investing
$0.0
Financing
$1.0M
USBC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
USBC vs Scientific & Technical Instrument Stocks
Usbc Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.